Tech Company Financing Transactions

OPX Biotechnologies Funding Round

On 4/7/2009, OPX Biotechnologies received $17.5 million in Series B funding from Braemar Energy Ventures, Altira Group and Mohr Davidow Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

2425 55th St. 100
Boulder, CO 80301
USA

Phone

(303) 243-5190

Website

www.opxbiotechnologies.com

Email Address

Not Recorded

Overview

OPX Biotechnologies, Inc. is a new company dedicated to enabling renewable fuels and chemicals that are economically and environmentally superior to petroleum-based products.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

David MacLennan

        

Browse more venture capital transactions:

Prev: 4/7/2009: Fisker Automotive venture capital transaction
Next: 4/7/2009: Socialcast venture capital transaction

Share this article

About Database of VC Transactions

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary